Overview
Poor sleep affects everything — recovery, cognition, metabolism, and immune function. Several peptides have shown promising effects on sleep quality, either as their primary action or as a beneficial side effect of growth hormone modulation.
This guide covers the most researched peptides for improving sleep, ranked by evidence and specificity.
1. DSIP (Delta Sleep-Inducing Peptide)
FDA Status: Research only
DSIP is a neuropeptide that was discovered in 1977 when researchers found it could induce delta wave (deep) sleep in rabbits. It remains the only peptide specifically named for its sleep-inducing properties.
Benefits:
- Promotes delta wave (Stage 3/4) deep sleep
- May normalize disrupted sleep patterns
- Reduces stress-related sleep disturbances
- Modulates cortisol and ACTH rhythms
Key evidence:
- Increased deep sleep duration in human studies
- Normalized sleep architecture in insomnia patients
- Reduced sleep latency (time to fall asleep)
- Modulated cortisol release patterns
Common protocol: 100-200mcg subcutaneously or intranasally 30-60 minutes before bed.
2. Ipamorelin
FDA Status: Research only
Ipamorelin is primarily a growth hormone secretagogue, but improved sleep quality is one of its most consistently reported benefits.
Why it helps sleep:
- Growth hormone is primarily released during deep sleep
- Ipamorelin enhances and extends natural GH pulses during sleep
- Users consistently report deeper, more restorative sleep
- Improved REM and slow-wave sleep patterns
Common protocol: 200-300mcg subcutaneously 30-60 minutes before bed.
3. MK-677 (Ibutamoren)
FDA Status: Research only
MK-677 has the strongest clinical evidence for sleep improvement among GH secretagogues.
Key evidence:
- A controlled study in young and elderly subjects showed a 50% increase in REM sleep and a 20% increase in Stage 4 (deep) sleep
- Improved overall sleep quality without causing daytime drowsiness
- Effects were sustained over 2 weeks of continuous use
Why it works: MK-677 increases GH secretion during sleep, particularly during the first sleep cycle. GH is closely linked to slow-wave sleep regulation.
Common protocol: 10-25mg oral before bed.
4. Selank
FDA Status: Approved in Russia, research elsewhere
Selank is an anxiolytic peptide that helps sleep indirectly by reducing anxiety and stress — two of the most common causes of insomnia.
Benefits:
- Reduces anxiety without sedation
- Normalizes GABA levels
- Improves stress resilience
- May help with sleep-onset insomnia caused by racing thoughts
How it works: Modulates GABA, serotonin, and dopamine systems. Acts as a stable analog of the endogenous peptide tuftsin.
Common protocol: 200-400mcg intranasally, 1-2 times daily. Can be used 30 minutes before bed for sleep-onset anxiety.
5. Epitalon
FDA Status: Research only
Epitalon is a tetrapeptide that activates telomerase and has been studied for its effects on circadian rhythm regulation and melatonin production.
Benefits:
- Stimulates natural melatonin production by the pineal gland
- May help regulate disrupted circadian rhythms
- Anti-aging effects through telomerase activation
- Restores natural sleep-wake cycles
Key evidence:
- Restored melatonin production in elderly subjects
- Normalized circadian cortisol rhythms
- Improved sleep quality in aged animal models
Common protocol: 5-10mg subcutaneously daily for 10-20 day cycles, 2-3 times per year.
Comparison Table
| Peptide | Primary Sleep Effect | Administration | Onset |
|---|---|---|---|
| DSIP | Delta (deep) sleep | Subcut/intranasal | 30-60 min |
| Ipamorelin | GH-mediated deep sleep | Subcut | 30 min |
| MK-677 | REM + deep sleep | Oral | 1-2 hours |
| Selank | Anxiety-related insomnia | Intranasal | 15-30 min |
| Epitalon | Melatonin restoration | Subcut | Days-weeks |